Medical patients are advised to be aware of recent pilot test results released by the National Collaborating Centre for Environmental Health. The tests showed that detectable levels of contaminants were present in 18 of the 20 cannabis samples tested. The most commonly detected contaminant was a fungicide called myclobutanil, which was found in 16 of the 18 samples. Other contaminants detected included a plant growth regulator called paclobutrazol and an insecticide called spiromesifen. Traces of bacteria, heavy metals, and other contaminants were also found in the samples.

The presence of these contaminants can pose serious health risks to consumers, including respiratory infections, organ damage, and cancer. It is important for medical patients to be aware of these risks and to take steps to protect their health.

To avoid the risks associated with contaminated cannabis products, medical patients are advised to obtain their cannabis from a legal and regulated source, such as a licensed producer or dispensary. These products are rigorously tested for safety and quality, and can provide patients with greater assurances of their safety and effectiveness.

In conclusion, the pilot test results released by the National Collaborating Centre for Environmental Health highlight the potential risks associated with contaminated cannabis products. Medical patients are advised to obtain their cannabis from a legal and regulated source in order to protect their health and avoid these risks.